Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (4262)	10/8/1999 6:16:00 PM
From: Mad2	Read Replies (1) \| Respond to of 10293

Hey Dan Any chance getting an answer to these; Message 11456585 I know you speculated on the return policy, but said nothing about the well worn rumor on the submission of a study by Hensley/Davidson on ZICAM's effectiveness to the New England Journal of Medicine. I asked when the Hensley/Davidson article was submitted to the NEJM? Dan the reason I believe this is important is I contacted NEJM and recieved the following response by e-mail from a editorial assistant at NEJM: Mr. ** On average, it takes 6-8 weeks for a decision to be reached. If accepted, production time to publication time is typically 5 months. Sincerely, Lauren Muckian Editorial Assistant In a earlier response (that's on my other computer), the same writer from NEJM advised they don't comment on the status of a article/submission except to the writer** of the article. As I believe this rumor has been floated for over two months (perhaps longer as I don't recall when it first cropped up, it seems to me that Dr. Hensley/Davidson should know the status of this. Either it's been rejected or accepted. If it's the latter and NEJM follows their normal production cycle it would be roughly 5 months from acceptance till production. What's up Dan? Mad2